Multi-Country Herpes Immunotherapy Clinical Study Continues
Mar 5, 2024 · This multi-country research study is recruiting 332 healthy participants aged 18-40 years or those aged 18-60 years with recurrent genital herpes. Known as GSK3943104A, GSK Study #215336 is forecasted to conclude in May 2026. This HSVTI study will explore different formulations and be conducted in two parts:
U.S. Government Takes Herpes Vaccine Development Lead
Apr 4, 2024 · To address this shortcoming, the U.S. government issued a Notice of Special Interest (NOSI) NOT-AI-24-028 on March 27, 2024, intending to stimulate additional focus on developing diagnostics, therapeutics, and vaccines targeting HSV. This NOSI, issued by the U.S. National Institute of Allergy and Infectious Diseases, focuses on furthering the ...
mRNA Norovirus Vaccine Candidate Launches Phase 3 Clinical Trial
Oct 1, 2024 · Moderna, Inc. today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403. As of October 1, 2024, no U.S. FDA-approved norovirus vaccines are available.
HSV Treatment Readies for Approval — Precision Vaccinations News
Mar 29, 2023 · A recently published Original Article reported positive news regarding the First-in-Human clinical trials assessing Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor targeting the Herpes Simplex Virus (HSV). As an active ingredient in a new chemical class (thiazolylamides), Pritelivir is active against both types of herpes, HSV-1 and HSV-2.
Welcome to Precision Vaccinations News
4 days ago · Latest Vaccine Breaking News. Chikungunya Outbreaks Approaching Unfortunate Record in 2024Chikungunya disease is vaccine preventable. Chikungunya. Malaria Day in the Americas 2024Malaria is a vaccine preventable disease. Malaria. Chikungunya Symptoms Detected Seven Years LaterChikungunya vaccine commercially available in 2024.
Ruvidar™ Found Effective in Destroying Herpes Simplex Virus
Sep 4, 2024 · However, Acyclovir will not cure herpes. To address this need, Theralase® Technologies Inc. today announced that its lead drug formulation, Ruvidar™, could be more effective in destroying HSV-1 than Acyclovir. Another important pre-clinical observation is that Acyclovir could not prevent HSV-1 replication if added one day after infection.
Needle-Free RSV Vaccine Could Be Delivered Through the Skin
Oct 28, 2024 · Furthermore, Vaxxas’ proprietary HD-MAP offers the potential for the first needle-free, room-temperature stable RSV vaccine. The Vaxxas HD-MAP comprises thousands of microscopic projections molded into a small patch. Each microprojection is coated with a small dose of vaccine in a dried formulation. When applied to the skin using a ...
21-Valent Pneumococcal Conjugate Vaccine Recommendations …
Sep 13, 2024 · The U.S. Centers for Disease Control and Prevention (CDC) today published updated recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding the use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults. On September 12, 2024, the CDC's MMWR confirmed the U.S. Food and Drug Administration approved 21-valent pneumococcal conjugate vaccine (PCV) (PCV21 ...
New World Screwworms Have Returned to Central America
Nov 4, 2024 · New World screwworm (NWS) infestations have continued to be reported in the Region of the Americas this year, and the U.S. government is concerned that NWS maggots may return after five decades. According to a notice issued by the U.S. Department of Agriculture on November 1, 2024, NWS is endemic in Cuba, Haiti, the Dominican Republic, and countries in South America.
34 Countries Identified in the Latest Polio Outbreak Alert
The Global Polio Eradication Initiative (GPEI) released its weekly update, which indicated that three countries reported new polio cases as the poliovirus continues to spread in 2024. On June 19, 2024, the GPEI reported that Afghanistan confirmed one wild poliovirus type 1 (WPV1), bringing the total number of cases in 2024 to six. Nigeria reported three cases of circulating vaccine-derived ...
- Some results have been removed